探索互联网抑郁症治疗(IBAT-D)在WEIRD与非WEIRD样本中同伴支持与无同伴支持的跨文化有效性:一项随机对照试验研究方案
该随机对照试验将在瑞士和印度纳入轻中度抑郁参与者,随机分为Deprexis自助组、Deprexis加同伴支持组和等待名单对照组,每组80人,干预8周,主要结局为干预后8周抑郁症状,并探讨文化差异及奖赏系统功能。
要点
- 研究比较Deprexis自助项目加同伴支持与不加同伴支持及等待名单对照的效果。
- 纳入轻中度抑郁参与者,每组80人,干预8周,随访至干预后3个月。
- 主要结局为干预后8周抑郁症状,同时探索奖赏反应与文化差异。
核心结论
- 本研究探讨包括同伴支持论坛和Deprexis项目在内的互联网自助干预在全球范围内应对抑郁的潜力。
- 研究调查为将全球可用的在线精神卫生保健整合到现有卫生系统以弥合治疗差距和改善结局,可能需要在多大程度上进行文化适应。
- 未来研究应探索这些干预在不同文化环境中的有效性及其长期影响。
研究设计与样本
- 研究为随机对照试验,纳入轻中度抑郁参与者,随机分为三组,每组80人:单用Deprexis组、Deprexis加同伴支持组和等待名单对照组。
- 干预持续8周,在基线(T0)、干预中期(4周,T1)、干预后(8周,T2)和随访(干预后3个月,T3)进行测量。
- 参与者通过RedCap完成在线问卷,并完成Fribourg奖赏任务。
- 研究在ClinicalTrials.gov(NCT06480474)和瑞士国家临床试验(SNCTP000005917)注册,于2024年5月获沃州伦理委员会(CER-VD)批准(方案日期:2024年5月22日;版本:4;2023-D0112)。
- 招募于2024年6月开始,预计2026年5月结束。
主要发现
- 主要结局为干预后8周抑郁症状。
- 次要结局包括对奖赏、愉悦和社会支持的情绪反应,以及焦虑、压力、生活质量、PTSD、童年创伤、自我效能和自尊等调节变量与中介变量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Internet-based self-help interventions (IBIs) have proven effective in reducing depression, especially in high and middle-income countries, and have proven to be flexible and location-independent. However, unguided IBIs often face high dropout rates, low uptake, lower adherence, and reduced effectiveness. OBJECTIVE: This study evaluates the effectiveness of a self-help program against depressive symptoms (Deprexis) with or without peer-to-peer support, focusing on cultural differences between WEIRD (Western, Educated, Industrialized, Rich, and Democratic) and non-WEIRD countries, specifically Switzerland and India. Additionally, this research explores Deprexis's efficacy in French-speaking Switzerland, aiming to extend its benefits to this demographic. The study also investigates mood responses to monetary and social rewards using the Fribourg Reward Task to understand the relationship between depression and reward system dysfunction in a cross-cultural context. METHODS: The study is a randomized controlled trial; participants with mild to moderate depression will be randomized into three groups of 80 each: Deprexis only, Deprexis with peer-to-peer support, and a control group on a waiting list. The intervention lasts 8 weeks, with measurements at baseline (T0), mid-intervention (4 weeks, T1), post-intervention (8 weeks, T2), and follow-up (3 months post-intervention, T3). Participants will complete online questionnaires on RedCap and the Fribourg Reward Task. PRIMARY OUTCOME: depressive symptoms at 8 weeks post-intervention. SECONDARY OUTCOMES: mood responses to reward, pleasure, and social support, with moderators and mediators like anxiety, stress, quality of life, PTSD, childhood trauma, self-efficacy, and self-esteem. RESULTS: The study, registered at ClinicalTrials.gov (NCT06480474) and Swiss National Clinical Trials (SNCTP000005917), was approved by the Ethics Committee of Vaud (CER-VD) in May 2024 (protocol date: 22.05.2024; version: 4; 2023-D0112). Recruitment began in June 2024 and is expected to end in May 2026. CONCLUSION: This study examines the potential of IBIs, including peer-to-peer support forums and the Deprexis program, in addressing depression globally. It investigates the extent to which cultural adaptations may be required in order to integrate globally available online mental health care into existing health systems to bridge treatment gaps and improve outcomes. Future research should explore these interventions' effectiveness in diverse cultural settings and their long-term impacts.
引用
- Tandon T, Berger T, Meyer B, et al. Exploring cross-cultural effectiveness of internet-based depression treatment (IBAT-D) with peer-to-peer support vs. without across WEIRD and non-WEIRD samples: a research protocol for a randomized controlled trial. Trials. 2025. PMID: 41382119. doi:10.1186/s13063-025-09377-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。